Biomanufacturing and Jobs Act of 2025

# Biomanufacturing and Jobs Act of 2025 - Summary **What the Bill Would Do:** The Biomanufacturing and Jobs Act of 2025 is a proposed law currently being reviewed in Congress. Based on its title, the bill appears designed to support the growth of biomanufacturing—the production of medicines, vaccines, and other products using living organisms or biological processes. However, specific details about what the bill contains are not publicly available yet, as it has not advanced far enough in the legislative process for detailed information to be widely documented. **Who It Affects and Current Status:** If passed, this bill would likely impact biotechnology companies, pharmaceutical manufacturers, workers in those industries, and potentially consumers who use biologically-produced medicines and treatments.

The bill is currently in committee, meaning it's in an early stage of review where lawmakers examine its provisions before deciding whether to bring it to a full vote. Introduced by Representative Mark Alford (R-MO), the bill has not yet moved forward for debate or passage. **Note:** For detailed provisions, you may want to check Congress.gov or contact the bill's sponsor's office, as the complete text and specific details are not included in this summary.